Valeant Pharmaceuticals International (NYSE:VRX)

CAPS Rating: 3 out of 5

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology.

Recs

0
Player Avatar PilotF22 (76.28) Submitted: 9/30/2010 11:42:12 AM : Outperform Start Price: $24.00 VRX Score: +86.24

sg

Featured Broker Partners


Advertisement